1. Curriculum Vitae
Jose
F.
Caro,
M.D.
Artist
Dis/nguished
Professor
of
Medicine
Emeritus
General
Informa/on
Home
Address:
5947
McKinges
Circle
Carmel,
IN
4603
Telephone:
252-­‐414-­‐1738
Email:
jfcaro13@gmail.com
webs:
www.josefcaro.com
www.linkedin.com/in/josefcaro
Birthplace:
Granada,
Spain;
June
27,
1948
CiUzenship:
USA
Marital
Status:
Married
with
Marice
E.
Caro
for
42
years
Children:
Maricelina,
Rodolfo,
Marina
and
Rafael
Grand
Children:
Olivia,
Elise,
Bridget,
Julia
and
Julian
Summary
Jose F. Caro began a new career in art in 2008. He went back to college to pursue a degree in fine art
and is having his pastel paintings peer reviewed by his colleagues. Before this transformation he was the
Vice President of Endocrine Research and Clinical Investigation and Global Diabetes Care at Eli Lilly &
Comp for 12 years. Prior to joining Lilly he was the Magee Professor of Medicine and Chairman of the
Department at Jefferson Medical College for 5 years and the Chief of Endocrinology and Director of the
University Diabetes Center at East Carolina University for 10 years.
Dr. Caro received his M.D. degree with honors in 1973 from the School of Medicine in Madrid, Spain and
Montevideo, Uruguay. He completed residency and fellowship training at Jefferson Medical College and
at the University of Rochester. He is Board Certified in Internal Medicine and Endocrinology and
Metabolism.
Dr. Caro was a member of various professional and honorary societies, including the American Society
for Clinical Investigation (Young Turk) and the Association of American Physicians (Old Turk). He was the
recipient of the Medal of Honor and is an honorary member of the Real Academy of Medicine of Granada,
Spain. He is the Honorary Director of the Peking Diabetes Center and Honorary Professor of the Peking
University Health Science Center in China.Dr.
He has authored about 200 papers, book chapters and books and he was recently listed as the third most
highly cited investigator in the world in the field of Obesity Research by ISI. He served as Editor and
Editorial Board member of several journals and has lectured around the world. Dr. Caro has served as a
member and Chairman of several study sections at the NIH and more recently as a member of the NIDDK
Advisory Council to the President.
He lives in Carmel IN with Marice, his spouse for 42 years. His main artistic inspiration is his family...his
four children and five grandchildren.

2. ________________________ART_______________________________
Why
a
Second
Career
in
Art?
My great granduncle, Rafael Eiroa, was an artist in the late XIX century Spain. One of his paintings was in
my parents’ home. It was a middle age woman sitting in a dilapidated straw chair. Her eyes were unfixed
and gazed into space. It was almost as if she was waiting to catch the opportunity she did not have.
Every night I fell to sleep thinking about her, about opportunities, the future, and most definitively that I
wanted to paint like my uncle Rafael.
After the Spanish Civil war, my family like many others immigrated to Argentina looking for the freedom
they did not have. I still remember vividly those 21 days crossing the ocean aboard the steamship Buena
Esperanza (Good Hope). My great granduncle’s large canvas was carefully removed from the frame by
my father, rolled and stored into a trunk labeled “memories from Spain”.
Many years had passed before my mother decided to open the trunk. The canvas was severely
damaged. I was a teenager and had forgotten the woman sitting in a chair. Nevertheless, my parents
knowing my interest for art suggested that I repair her. I bought oils and brushes and I did it! I knew then
what I wanted to become. But when I told my father about my desire to enter the school of art he said
“study son, you will always have time to paint”.
I became a physician and soon after graduation I moved to the USA with my wife and daughter looking for
freedom and opportunities, like my parents did. It has been a great 40 years journey but I never found
time to paint like my father said. Thus, I left medicine and science at age 60 to find time to paint. My
youngest son Rafael after reading this statement he smiled and firmly said “I will start a career in art this
fall semester”. If I finish wanting to paint like my uncle Rafael and my son Rafael, I would say it is not a
bad way to end.
Presentations at Juried Shows.-
2009 Greenville Museum of Art Annual Juried Show. Greenville, NC
“Only in California” and “The Magic Five Minutes in the Morning”
2011 Pastel Society of North Carolina, Winter Exhibition. Greensboro, NC
“The Beach at Acadia National Park”
2013 Ninth Annual Northeast National Pastel Exhibition, Old Forge, NY
“I am not a little girl anymore”
2013 27th Annual International Exhibit. Northwest Pastel Society. Tacoma,
WA
“At Acadia National Park”
2013 First Carteret County Juried Art Show. Emerald Isle, NC
“Shall I grow up?” and “At the Poconos Mountains”

3. 2013 North Carolina Statewide Juried Pastel Exhibition. On Common
Grounds: Pastel Paintings From The Mountains To The Sea.
“I am not a little girl anymore”
2013 The 23rd International Association of Pastel Societies Juried
Exhibition. Marshfield, MA
“I am not a little girl anymore”
2014 The Southeastern Pastel Society’s 16th International Exhibition.
Oglethorpe University Museum of Art. Atlanta, GA
“I am Not Alone” and “Dreaming About Spring”
2014 28th Annual International Exhibit. Northwest Pastel Society.
Tacoma, WA
“At Acadia National Park”
2014 Northeast National Pastel Exhibition, View.Old Forge NY
“Maternity”
2014 Degas Pastel Society Fifteenth Biennial National Exhibition. New
Orleans, LA.
“Maternity” and “I am not alone”
2014 Southeastern Pastel Society On-Line Juried Exhibition.
“Choices”
2015 Pastel Society of the West Coast 2015 Annual Members Show.
Haggis Museum, Stockton, CA.
“I am not alone”
2015 Southeastern 2015 juried members exhibition. Quinlan Visual Art
Center, Gainesville, GA.
“Maternity”
2015 Degas Pastel Society Nineteenth Membership Exhibition. New
Orleans, LA
“Choices” and “I am not a little girl anymore”
2015 The Peninsula Art League 2015 Open Juried Show. Harbor
History Museum, Gig Harbor, WA
“Maternity” and “The hug”
One Person Shows.-
2013 Emerald Isle Recreation Center, Emerald Isle, NC

4. 2013 Bogue Banks Public Library, Pine Knoll Shores, NC
2013 Arts for the Hospital, Carteret Hospital, Morehead City, NC
Presentations at Non Juried Shows.-
2013 Art for the Heart Annual Exhibition. Carteret County Art Council.
Morehead City, NC .
“I am not a little girl any more” and “The beach at Emerald Isle”
Awards/Honors/Publications.-
2012 The Editor Choice: “Celebration of Water”. Art & Beyond Vol. 6,
page 16, 2012.
2013 Juried Associate Member of the Pastel Society of America (PSA)
2013 Featured Artist of the Week with “Are we ready to leave home” at
Artists Registry.com
2013 Featured Artwork @The Library. The Shoreline, Vol. 9, No. 8, p. 10
2013 Featured Pastel Artist. News-Time, Vol. 102, No.59, p.
2013 News and Mentions. Art Line, Pastel Society of NC. Vol. 2013 May
2014 The Artist’s Magazine. Annual Art Competition. Portrait/Figure
Third Place Winer “I am not a little girl anymore”
2015 Juried Full Member of the Degas Pastel Society.
2015 Juried Full Member Indiana Artists Club
Professional Societies and Memberships.-
2008 - 2012 The Indiana Art Association
2009 - Present Hoosier Salon, Patron Association and Fine Art Gallery
2009 - 2012 Northern Indiana Pastel Society
2012 - 2014 Craven Arts Council & Gallery, Inc., NC

5. 2012 - 2014 Seaside Arts Council, NC
2012 - 2014 Art Council of Carteret County, NC
2012- 2014 Pastel Society of North Carolina
2012- 2014 Greenville Museum of Art, NC
2013- Present Juried Associate Member Pastel Society of America (PSA)
2013- Present Northwest Pastel Society
2014- Present Southeastern Pastel Society
2014 - Present Juried member of the Degas Pastel Society
Invited Lectures. -
“The role of art in society”. Lookout Rotary Club, Morehead City, NC 2012
“The Past and Present of Pastel Painting”. At the Art for the Hospital Annual Meeting.
Carteret Community Hospital, Morehead City, NC 2013
Consultant/Advisory Activities. -
Member of the Board of Arts for the Hospital. Carteret County Community Hospital,
Morehead City, NC
Member of the Jury for Arts for the Heart, Student Category, Carteret County Art
Council, Morehead City, NC
Art education.-
2008-2010 Semester Courses in Fine Art at the Indianapolis Art Center.
2010-2012 Study Fine Art at CCC College, Morehead City, NC
2011-Present Participation at Workshops, critic sections and art classes with
experience artists such us W. Creevy, R. McKinley, P. Newell.

6. _______________________MEDICINE_____________________
MEDICAL
EDUCATION
1967
-­‐
1973
School
of
Medicine,
Universidad
Autonoma
de
Madrid,
Spain
and
School
of
Medicine,
Universidad
de
la
Republica,
Montevideo,
Uruguay
POSTGRADUATE
TRAINING
1974
-­‐
1977
Residency
in
Internal
Medicine,
Thomas
Jefferson
University
Hospital
of
Thomas
Jefferson
University,
Philadelphia,
Pennsylvania
1977
-­‐
1978
Fellowship
in
Internal
Medicine,
Thomas
Jefferson
University
Hospital
of
Thomas
Jefferson
University,
Philadelphia,
Pennsylvania
1978
-­‐
1981
Fellowship
in
Endocrinology
and
Metabolism,
Strong
Memorial
Hospital,
University
of
Rochester
School
of
Medicine
and
DenUstry,
Rochester,
New
York
CERTIFICATIONS
1979
Board
CerUficaUon
in
Internal
Medicine,
American
Board
of
Internal
Medicine
1984
Board
CerUficaUon
in
Endocrinology
and
Metabolism,
American
Board
of
Internal
Medicine
APPOINTMENTS
1981
-­‐
1983
Assistant
Professor
of
Medicine,
Endocrinology
and
Metabolism,
Jefferson
Medical
College
of
Thomas
Jefferson
University,
Philadelphia,
Pennsylvania
1983
-­‐
1986
Associate
Professor
of
Medicine,
SecUon
Head
of
Endocrinology
and
Metabolism,
East
Carolina
University
School
of
Medicine,
Greenville,
North
Carolina
1986
-­‐
1991
Professor
of
Medicine,
SecUon
Head
of
Endocrinology
and
Metabolism
and
Director
of
the
University
Diabetes
Center,
East
Carolina
University
School
of
Medicine,
Greenville,
North
Carolina
The
Division
of
Endocrinology
and
Metabolism
was
founded.
Six
faculUes
were
recruited
and
mentored
and
all
became
funded
by
the
NIH.
A
comprehensive
Fellowship
Program

7. was
approved.
The
ECU
Diabetes
and
Obesity
Center
was
established.
Dr.
J.
F.
Caro
became
Program
Director
of
the
“ECU
Diabetes
Program
Project”,
the
largest
NIH
award
in
the
history
of
the
University.
Basic
research
discoveries
were
made
such
as
mechanism(s)
of
IRTK
defects
in
liver,
muscle
and
liver
from
humans
with
diabetes
and
clinical
research
observaUons
were
made
such
as
that
the
gastric
bypass
surgery
prevent
diabetes
by
40
folds
in
people
with
pre-­‐diabetes
and
reverse
diabetes
in
more
than
80
percent
of
paUents
for
more
than
10
years.
1991
-­‐
1996
Magee
Professor
of
Medicine
and
Chairman
of
the
Department,
Jefferson
Medical
College
of
Thomas
Jefferson
University,
Philadelphia,
Pennsylvania
The
Department
of
Medicine
tripled
its
NIH
funding
and
moved
from
the
middle
third
to
the
upper
third
of
NIH
ranking.
The
residency
program
became
the
largest
in
the
State
with
most
house
staff
elecUng
a
career
on
primary
care.
Out
paUent
encounters
tripled
and
hospital’s
paUent
duraUon
of
hospitalizaUon
decreased
by
half.
The
budget
of
the
Department
conUnued
generaUng
overage
for
program
development.
All
this
was
achieved
without
a
significant
increase
in
FTEs.
This
is
what
our
Dean
called
“producUvity
without
expansion”
1996
-­‐
2008
Vice
President,
Endocrine
Research
and
Clinical
InvesUgaUon
and
Vice
President
of
Global
Diabetes
Care.
Lilly
Research
Laboratories,
Eli
Lilly
&
Comp,
Lilly
Corporate
Center,
Indianapolis,
IN
The
focus
was
on
drug
discovery
from
hypothesis
generaUon
in
the
laboratory
to
prove
of
concept
in
phase
2
clinical
trials.
The
effort
involved
a
heavily
matrix
organizaUon
with
chemistry,
toxicology,
ADME,
biology,
clinical
pharmacology,
markeUng,
business,
etc.
More
than
40
compounds
were
discovered
that
fulfilled
all
FDA
requirements
to
enter
clinical
trials.
The
endocrine
porlolio
transformed
from
only
Insulin
to
a
more
complete
porlolio
with
several
INDs
and
NDAs
sUll
in
clinical
trials
from
this
decade’s
drug
discovery
pipeline.
1996
-­‐
2008
Professor
of
Medicine,
Indiana
University
School
of
Medicine
Indianapolis,
IN
2005
-­‐
Present
DisUnguished
Professor
of
Medicine,
Emeritus,
East
Carolina
University
School
of
Medicine,
Greenville,
NC
2007
–
Present
Co-­‐Founder,
Chief
ScienUfic
Officer
Emeritus
and
Honorary
Member
of
the
ExecuUve
Commioee
of
Peers
for
Progress.
AAFP,
University
of
North
Carolina,
Chapel
Hill,
NC
2012-­‐Present
President
and
Founder,
JFC
SoluUons
LLC
AWARDS
AND
RESEARCH
GRANTS
(direct
cost
only)
1979
-­‐
1981
Juvenile
Diabetes
FoundaUon
Fellowship
Award
(P.I.)

8.
($75,000)
1981
-­‐
1983
American
Diabetes
AssociaUon
Wayne
Newton
Research
Grant
(P.I.)
($68,750)
1981
-­‐
1982
Small
Grant
Award
PHS
Biomedical
Research
Support
Grant
5
S07RR0514,
Jefferson
Jefferson
Medical
College
(P.I.)
($120,000)
1981
-­‐
1982
Department
of
Medicine
Research
Grant,
Jefferson
Medical
College
(P.I.)
($12,500)
1981
-­‐
1983
Juvenile
Diabetes
FoundaUon
Research
Grant
(P.I.)
($110,000)
1982
-­‐
1983
Research
Grant,
Upjohn
Company
(P.I.)
($31,250)
1982
-­‐
1985
New
InvesUgator
Research
Award
1
R23AM
30558,
NaUonal
InsUtutes
of
Health
(PI)
($176,500)
1984
-­‐
1985
Research
Grant,
5-­‐81011
Years
Laboratories
(P.I.)
($43,750)
1985
-­‐
1987
Research
Grant,
Upjohn
Company
(P.I.)
($50,000)
1985
-­‐
1988
Research
Grant,
R01-­‐AM
32585
NaUonal
InsUtutes
of
Health
(P.I.)
($297,000)
1986
-­‐
1990
Research
Grant,
R01-­‐DK
38066
NaUonal
InsUtutes
of
Health
(P.I.)
(This
grant
was
funded
but
was
inacUvated
because
of
overlap
with
the
Program
Project
DK
36296
1987
-­‐
1988
Sponsor
of
Fogerty
Fellowship
Award
from
the
NaUonal
InsUtutes
of
Health
(IF05TW04048)
to
Dr.
Ivan
Contreras
1987
-­‐
1992
ECU
Diabetes
Program
Project,
P01-­‐DK
36296
NaUonal
InsUtutes
of
Health
(Program
Director)
($2,550,000)
1987
-­‐
1992
Research
Grant,
Eli
Lilly
Company
(P.I.)
($375,000)
1988
-­‐
1989
Research
Grant,
Glaxo
PharmaceuUcal
Company
(P.I.)
($62,500)
1988
-­‐
1989
Research
Grant,
R03-­‐DK
41191-­‐1
NaUonal
InsUtutes
of
Health
(P.I.)
($41,250)
1988
-­‐
1989
Research
Grant,
Pfizer
PharmaceuUcal
Company
(P.I.)
($30,000)

9. 1989
-­‐
1992
Sponsor
of
Fellowship
Award
from
the
NaUonal
InsUtutes
of
Health
(IF32DK08477)
to
Dr.
Jacob
Friedman
1990
-­‐
1991
Research
Grant,
Park
Davis
PharmaceuUcal
Company
(P.I.)
1990
Small
Grant
Award:
Roaring
VisiUng
Professorship
Program
in
Diabetes
Management
($6,250)
1990
Research
Grant,
1R03-­‐DK
2924
NaUonal
InsUtutes
of
Health
(P.I.)
($41,250)
1990
-­‐
1992
Research
Grant,
Amylin
PharmaceuUcal
Company
(P.I.)
($100,000)
1991
-­‐
1993
Sponsor
of
Fellowship
Award
to
Dr.
Bartolome
Burguera
from
the
Juvenile
Diabetes
FoundaUon
1991
-­‐
1992
Research
Grant,
Hoechst-­‐Roussel
PharmaceuUcals,
Inc.
(P.I.)
($62,500)
1992
-­‐
1994
Sponsor
of
Fellowship
Award
to
Dr.
Robert
Considine
from
the
NaUonal
InsUtutes
of
Health
(IF32DK08888)
1993
-­‐
1994
Research
Grant,
Eli
Lilly
Company
(P.I.)
($96,015)
1993
-­‐
1994
Research
Grant,
Eli
Lilly
Company
(Co-­‐PI)
($65,235)
1993
-­‐
1995
Research
Grant,
Amylin
PharmaceuUcal,
Inc.
(P.I.)
($37,676)
1994
-­‐
1995
Research
Grant,
Miles
Laboratories
(P.I.)
($153,125)
1994
-­‐
1995
Research
Grant,
Pfizer
PharmaceuUcals
(Co-­‐Invest.)
($37,500)
1994
-­‐
1996
Research
Grant,
CI-­‐991,
Park
Davis
PharmaceuUcals
(Co-­‐Invest.)
($47,000)
1992
-­‐
1997
Research
Grant,
R01-­‐DK
44950
NaUonal
InsUtutes
of
Health
(P.I)
($1,900,000)
1994
-­‐
2002
Research
Grant,
UO1-­‐DK48468,
NaUonal
InsUtutes
of
Health
(P.I.)
($3,422,165)

10. SPECIAL
RESEARCH
GRANTS
2006-­‐2012
Bringing
Research
In
Diabetes
Through
Environment
and
Systems
(BRIDGES).
See
Press
Release
Cape
Town,
South
Africa,
5
December
2006
BRIDGES@IDF.org
Dr.
Caro
idenUfied
the
need
of
translaUonal
research
in
diabetes
at
the
global
level.
He
wrote
a
Grant
to
the
Lilly
FoundaUon
and
provided
support
to
the
InternaUonal
Diabetes
FederaUon.
($10,000,000)
2007-­‐2012
Peers
for
Progress.
See
Press
Release
Leak
wood,
KS,
USA,
June
20,
2007,www.lilly.com/
product/acceess/foundaUon,
Peersforprogress.org
Dr.
Caro
idenUfied
the
need
of
new
methods
for
paUent
educaUon
in
diabetes.
He
wrote
a
Grant
to
the
Lilly
FoundaUon
and
provided
support
to
the
American
Academy
of
Family
Physicians
FoundaUon.
Peers
for
progress
will
idenUfy
and
train
laid
volunteers
who
have
diabetes
and
empower
them
to
assist
other
people
with
diabetes.
The
goal
is
to
educate
one
percent
of
the
people
with
diabetes
or
two
million
diabetes
to
become
mentors
around
the
world.
The
concept
was
validated
at
a
World
Health
OrganizaUon
consultaUon,
5-­‐7
November
2007
in
Geneva.
($15,000,000)
HONORS
AND
NAMED
LECTURESHIPS
1986-­‐1992
Recipient
of
the
“
Pearl
Lecturer”
every
year
while
in
the
Faculty
(Senior
Medical
Students'
Teaching
Award).
East
Carolina
University
School
of
Medicine,
Greenville,
NC
1988
-­‐2012
Member
of
the
American
Society
of
Clinical
InvesUgators
(Young
Turk)
1991
Outstanding
InvesUgator
Award.
Department
of
Medicine
Fish
Annual
Research
Day,
East
Carolina
University
School
of
Medicine,
Greenville,
NC,
1991.
1992
Karl
Paschkis
Lecturer,
"NIDDM:
Lessons
from
the
Laboratory."
The
Philadelphia
Endocrine
Society,
Philadelphia,
Pennsylvania,
1992.
1993
Bernardo
A.
Houssay
Lecturer,
"Insulin
Resistance
in
Type
II
Diabetes",
InternaUonal
Diabetes
FoundaUon
and
The
Costa
Rican
AssociaUon
of
Endocrinology,
San
Jose,
Costa
Rica,
1993.
1996
Mithoffer
Lecturer,
"LepUn:
The
Tale
of
an
Obesity
Gene",
Medical
University
of
South
Carolina,
Charleston,
SC,
1996.
1996
Alexander
Marble
Lecturer,
“Obesity:
A
syndrome
of
LepUn
Resistance”.
Joslin
Diabetes
Center.
Harvard
Medical
School.
Boston,
Massachuseos,
1996.
1997
BanUng
and
Best
Lecturer:
“Discovery
of
LepUn”.
University
of
Toronto.
Canada
Diabetes
AssociaUon.
Toronto,
Canada,
1997
1998
Eugene
Furth
Lecturer
“On
the
trail
to
cure
Diabetes”
East
Carolina
University
School
of
Medicine,
Greenville,
North
Carolina,
1998

11. 1998
A.M.
Cohen
Memorial
Lecturer:
“On
the
Trail
to
Cure
Diabetes”.
VII
InternaUonal
Symposium
on
Insulin
Receptors
and
Insulin
AcUon:
Molecular
and
Clinical
Aspects.
Jerusalem,
Israel,
1998
1998
Recipient
of
the
Medal
of
Honor
and
Honorary
Membership
to
the
Real
Academy
of
Medicine
of
Granada.
Granada,
Spain,
1998
1991
-­‐
2001
The
third
most
highly
cited
invesUgators
in
the
field
of
Obesity
Research
by
the
InsUtute
for
ScienUfic
InformaUon
(I.S.I).
2000
-­‐
2012
Member
of
the
AssociaUon
of
American
Physicians
(Old
Turk)
2004
-­‐
present
Honorary
Director
of
the
Peking
Diabetes
Center
and
Honorary
Professor
of
the
Peking
University
Health
Science
Center.
Peking,
China.
2005
The
Leslie
Nicholas
Lecture
“The
scienUfic
Basis
of
New
Therapies
for
Obesity”.
The
College
of
Physicians
of
Philadelphia,
PA
EDITORIAL
ACTIVITIES
1988
-­‐
1996
Associate
Editor,
Advances
in
Diabetologia
1991
-­‐
1997
Associate
Editor,
Diabetes
Care
1991
-­‐
2002
Editorial
Board,
Journal
of
Clinical
Endocrinology
and
Metabolism
1992
-­‐
2002
SecUon
Editor,
Obesity
Research,
North
American
AssociaUon
for
the
Study
of
Obesity
1994
-­‐
1999
Associate
Editor,
Medicina
y
Cultura
1985
-­‐
2008
Associate
Editor,
Metabolism
Clinical
and
Experimental
2001
-­‐2005
SecUon
Editor,
NutriUon
and
Obesity,
Endotext.com
2004
-­‐
2006
Co-­‐Editor,
The
Metabolic
Syndrome
at
the
Beginning
of
the
XXI
Century:
A
GeneUc
and
Molecular
Approach
2005
-­‐
2008
Editorial
Board,
Journal
of
Clinical
Endocrinology
and
Metabolism
2005
–
2008
InternaUonal
Editorial
Board,
Obesity
and
Metabolism
CONSULTANT
ACTIVITIES
TO
NIH
1985
-­‐
1989
Member,
Metabolism
Study
SecUon,
NaUonal
InsUtutes
of
ArthriUs,
Diabetes
and
Kidney
Diseases.
NaUonal
InsUtutes
of
Health
1989
Special
Reviewer,
Study
SecUon
for
Small
Business
InnovaUon
Research,
Pharmacology
Panel,
NaUonal
InsUtutes
of
Health

12. 1989
Member,
Site
Visit
Team,
General
Clinical
Research
Center
Commioee.
NaUonal
InsUtutes
of
Health
1989
Member,
Site
Visit
Team
to
review
a
NIH
General
Clinical
Research
Center
1990
Member,
Clinical
Sciences
Study
SecUon
Site
Visit.
NaUonal
InsUtutes
of
Health
1991
Member,
NIH
Site
Visit
Team,
General
Clinical
Research
Center
1992
Member,
Special
Review
Commioee,
NaUonal
InsUtute
of
General
Medical
Sciences,
NIH
1992
Member,
External
Advisory
Commioee,
Sims'
Obesity
and
NutriUon
Research
Center,
NIDDK
and
NICHD
1992
Member,
NIDDK
Special
Grant
Review
Commioee
1992
Chairman,
Diabetes
Endocrinology
Research
Center
Study
SecUon,
NIH,
Bethesda,
Maryland
1992
Member,
Site
Visit
Team,
General
Clinical
Research
Center,
NaUonal
InsUtute
of
Health
1993
Chairman,
Ad
Hoc
Review
Group
SSS-­‐L
Clinical
Sciences
Review
SecUon,
NaUonal
InsUtute
of
Health.
1994
Member,
Behavioral
and
Neurosciences
Special
Emphasis
Panel,
NIH
1995
Member,
Ad
Hoc
Review
Commioee,
Diabetes
Research
and
Training
Centers,
NaUonal
InsUtute
of
Health
1998
Member,
Congressionally
Mandated
Diabetes
Research
Working
Group
and
Chairman
of
the
Industry/Academia
Subgroup,
NaUonal
InsUtute
of
Health
(NIH).
1996
-­‐
2000
Member,
Subcommioee
B
of
the
Diabetes
and
DigesUve
and
Kidney
Diseases
Special
Grants
Review
Commioee,
NaUonal
InsUtute
of
Diabetes
and
DigesUve
and
Kidney
Diseases
(NIDDK),
NIH
2000
-­‐
2004
Member
of
the
NaUonal
InsUtute
of
DigesUves
and
Diabetes
and
Kidney
Diseases
Advisory
Council,
NIH
and
Chairman
of
the
Concurrence
Grant
Awards
Approval
Commioee
of
the
NIDDK
Advisory
Council,
NIH
2000
–
2004
Member
of
the
Disease
PrevenUon
and
Management
Working
Group,
Advisory
Council
of
the
NaUonal
InsUtute
of
Diabetes
and
DigesUve
and
Kidney
Diseases,
NIH
2000
–
2004
Member
of
the
Advisory
Council
OperaUng
Procedures
Working
Group,
NIDDK
Advisory
Council,
NIH

13. CONSULTANT
ACTIVITIES
TO
THE
AMERICAN
DIABETES
ASSOCIATION
1984
-­‐
1985
Chairman,
PaUent
EducaUon
Commioee,
American
Diabetes
AssociaUon,
North
Carolina
1984
-­‐
1985
President,
American
Diabetes
AssociaUon,
Pio
County
Chapter,
North
Carolina
1985
-­‐
1986
Chairman,
PaUent
EducaUon
Commioee,
American
Diabetes
AssociaUon,
North
Carolina
Affiliate
1988
-­‐
1991
Member,
Professional
EducaUon
Commioee,
American
Diabetes
AssociaUon
1989-­‐1991
Member,
Commioee
on
ScienUfic
and
Medical
Profession.
American
Diabetes
AssociaUon
1992
Member,
Grant
Review
Panel,
Studies
on
GeneUcs
in
NIDDM,
American
Diabetes
AssociaUon,
New
York,
NY.
1989-­‐1991
Master
Faculty,
Clinical
EducaUon
Program,
"Managing
Diabetes
in
the
1990's,"
American
Diabetes
AssociaUon.
1990
-­‐
1991
President
Elect,
American
Diabetes
AssociaUon,
North
Carolina
Affiliate
1991
-­‐
1992
President,
American
Diabetes
AssociaUon,
North
Carolina
Affiliate
1992
-­‐
1996
Member,
Board
of
Directors,
American
Diabetes
AssociaUon,
Pennsylvania
Affiliate
1992
-­‐
1996
Member,
Professional
EducaUon
Commioee,
American
Diabetes
AssociaUon,
Pennsylvania
Affiliate
1993
Panel
member,
Consensus
Development
Conference
on
the
Treatment
of
Hypertension
in
Diabetes,
American
Diabetes
AssociaUon
1993
-­‐
1996
Member
of
the
Academic
Steering
Commioee,
Professional
Diabetes
Academy
1994
-­‐
1996
Chairman,
ScienUfic
and
Medical
MeeUngs
Oversight
Commioee
of
the
American
Diabetes
AssociaUon
1994
-­‐
1996
Member,
Professional
SecUon
Advisory
Panel
of
the
American
Diabetes
AssociaUon
MEDICAL
SCHOOL
COMMITTEES
1985
-­‐
1986
Member,
Policy
and
Review
Commioee
on
Human
Research,
East
Carolina
University
1985
-­‐
1986
Member,
House
Staff
EvaluaUon
Commioee,
East
Carolina
University
1985
-­‐
1991
Member,
Human
Organ
Transplant
Commioee,
East
Carolina
University
1985
-­‐
1991
Member,
Department
of
Medicine
Research
Advisory
Commioee,
East
Carolina
University
1986
-­‐
1987
Member,
RadiaUon
Safety
Commioee,
East
Carolina
University

14. 1986
-­‐
1987
Member,
InsUtuUonal
Review
Commioee,
Pio
County
Memorial
Hospital
1987
-­‐
1988
Member,
Dean's
Search
Commioee
(Elected
by
the
Faculty),
East
Carolina
University
1987
-­‐
1991
Member,
Jacob
Furth
Prize
Commioee,
East
Carolina
University
1989
-­‐
1990
Chairman,
Ad
Hoc
Commioee,
Clinical
Research
Center,
School
of
Medicine,
East
Carolina
University
1989-­‐1990
Member,
Ad
Hoc
Commioee,
Medical
School
Core
Laboratory
FaciliUes.
School
of
Medicine,
East
Carolina
University
1991
Member,
Search
Commioee
for
Chairman
of
the
Department
of
Medicine
(Elected
by
the
faculty),
East
Carolina
University
1995
-­‐
1996
Member,
University
Advisory
Commioee
on
InternaUonal
Affairs,
Thomas
Jefferson
University
1995
-­‐
1996
Secretary,
Jefferson
Faculty
FoundaUon
ExecuUve
Commioee,
Jefferson
Medical
College
1995
Member,
Jefferson
Faculty
FoundaUon
Finance
Commioee,
Jefferson
Medical
College
OTHER
CONSULTANT/COMMITTEE
WORK
1986-­‐1996
Ad
Hoc
Reviewer,
Research
Grants
Program.
Veterans
AdministraUon,
Washington,
DC
1988
-­‐
1992
Member
of
the
Medical
Science
Review
Commioee,
Juvenile
Diabetes
FoundaUon
InternaUonal
1989-­‐1999
Ad
Hoc
Reviewer,
NaUonal
Science
FoundaUon.
Washington,
DC
1989-­‐1991
Member,
Board
of
Medical
Advisors.
Amylin
CorporaUon,
San
Diego,
CA
1992
-­‐
1996
Member,
Board
of
Trustees,
Methodist
Hospital,
Philadelphia,
PA
1992
-­‐
1996
Member,
Board
of
Trustees,
Magee
RehabilitaUon
Hospital,
Philadelphia,
PA
1992
-­‐
1996
Member,
Board
of
Directors,
Philadelphia
Endocrine
Society
1993
-­‐
1996
Member,
Boston
Obesity/NutriUon
Research
Center
ScienUfic
Advisory
Group
1993
-­‐
1994
Member,
EducaUon
Commioee,
Professional
Diabetes
Academy
1994
-­‐
1996
Member,
Academic
Advisory
Commioee
of
the
Pfizer
VisiUng
Professorship
Program
in
Diabetes
Management
1994
Member,
Commioee
on
Faculty
and
Researchers,
Interamerican
College
of
Physicians
and
Surgeons

15. 2001
-­‐
2005
Member,
JDRF
Management
Advisory
Board
2004
Member,
American
Obesity
AssociaUon
Advisory
Board
PROFESSIONAL
SOCIETIES/MEMBERSHIPS
1976
-­‐2010
Member,
American
Society
of
Internal
Medicine
1977
-­‐2010
Member,
American
College
of
Physicians
1979
-­‐
2010
Member,
American
FederaUon
for
Clinical
Research
1980
-­‐
2010
Member,
American
Diabetes
AssociaUon
1980
-­‐
2010
Member,
Endocrine
Society
1984
-­‐
2010
Member,
American
AssociaUon
for
the
Advancement
of
Science
1984
-­‐
2010
Member,
American
Medical
AssociaUon
1984
-­‐
1992
North
Carolina
Medical
Society
1988
-­‐
2010
Member,
American
Society
for
Clinical
InvesUgaUon
(Young
Turk)
1991
-­‐
2010
Member,
Sigma
Xi,
The
ScienUfic
Research
Society
1992
-­‐
1997
Pennsylvania
Medical
Society
1992
-­‐
1997
Philadelphia
County
Medical
Society
1992
-­‐
1997
College
of
Physicians
of
Philadelphia
1992
-­‐
2010
Charter
Member,
American
AssociaUon
of
Clinical
Endocrinologists
1993
-­‐
2010
Fellow,
American
College
of
Physicians
1993
-­‐
2010
Member,
North
American
AssociaUon
for
the
Study
of
Obesity
1993
-­‐
2010
Member,
Professional
Diabetes
AssociaUon
1995
-­‐
2010
Member,
Society
of
Ibero
LaUn
American
Medical
Professionals
1996
-­‐
1997
Member,
American
Society
for
Clinical
Pharmacology
and
TherapeuUcs
2000
-­‐
2010
Member,
AssociaUon
of
American
Physicians
(Old
Turk)

16. SPECIAL
POST
GRADUATE
EDUCATION
1992
Program
for
Chiefs
of
Clinical
Services,
Harvard
School
of
Public
Health
1993
Program
for
ExecuUves
in
Managed
Care,
Harvard
School
of
Public
Health
VISITING
PROFESSORSHIPS
AND
SPECIAL
LECTURES
Invited
Speaker.
"Mechanism
of
Insulin
Resistance
in
Uremia."
University
of
Pennsylvania.
Philadelphia,
PA,
1981
Invited
Speaker.
"Insulin
Binding
and
Processing
in
Isolated
Rat
Hepatocytes."
University
of
Virginia.
Charlooesville,
VA,
1981
Invited
Speaker.
"Insulin
Resistance
in
Uremia."
University
of
South
Florida.
Tampa,
FL,
1982
Invited
Speaker.
"Insulin
Resistance
in
Uremia."
Duke
University
School
of
Medicine.
Durham,
NC,
1982
Program
Chairman.
"The
Diagnoses
and
Treatment
of
Type
II
Diabetes."
American
Diabetes
AssociaUon
and
East
Carolina
University
School
of
Medicine.
Greenville,
NC,
1984
Invited
Speaker.
"Management
of
Type
II
Diabetes."
At
the
"First
Congress
in
Washington,
DC
of
the
Interamerican
College
of
Physicians
and
Surgeons."
Washington,
DC,
1984
Invited
Speaker.
"Mechanism
of
Insulin
AcUon"
and
"Hyperlipidemia
in
Diabetes."
The
Third
Annual
ScienUfic
Panel
and
the
University
of
Zulia.
Maracaibo,
Venezuela,
1985
Invited
Speaker.
"Gastric
Bypass:
A
Human
Model
to
Study
Diabetes."
Duke
University
School
of
Medicine.
Durham,
NC,
1985
VisiUng
Professor.
"Mechanism
of
Insulin
Resistance
in
the
Human
Liver
from
PaUents
with
NIDDM."
University
of
Rochester
School
of
Medicine
and
DenUstry.
Rochester,
NY,
1986
Moderator.
"Learn
by
Sharing."
PaUent
EducaUon
Program
of
the
American
Diabetes
AssociaUon,
North
Carolina
Affiliate.
Raleigh,
NC,
1985
Invited
Speaker.
"DiabeUc
Emergencies"
and
"Office
Management
of
Type
II
Diabetes."
14th
Annual
Beach
Workshop.
Myrtle
Beach,
SC,
1986
Invited
Speaker.
"Insulin
Receptor
Kinase
AcUvity
in
Human
Liver,
Muscle,
and
Adipose
Tissue."
Lilly
Research
Laboratories.
Indianapolis,
IN,
1986
VisiUng
Professor.
"ECU
Diabetes
Program
Project."
Diabetes
Branch
of
the
NaUonal
InsUtutes
of
Health,
Bethesda,
MD,
1986
VisiUng
Professor.
"Mechanism
of
Insulin
Resistance
in
Type
II
Diabetes."
Geriatric
Research
Center,
Johns
Hopkins
University
School
of
Medicine.
BalUmore,
MD,
1986
VisiUng
Professor.
"The
Mechanism
of
Insulin
Resistance
in
Type
II
Diabetes."
Department
of
Pathology,
University
Complutense
School
of
Medicine.
Madrid,
Spain,
1986

17. Invited
Speaker.
"The
Human
Endocrine
System:
A
Brief
Review."
At
the
Fourth
Annual
Biotechnology
Symposium."
East
Carolina
University
School
of
Medicine.
Greenville,
NC,
1986
VisiUng
Professor.
"Insulin
Receptor
Kinase
in
Important
Target
Tissues
for
Insulin
in
Type
II
Diabetes
Mellitus."
Department
of
Medicine,
University
of
Rochester
School
of
Medicine
and
DenUstry.
Rochester,
NY,
1987
Invited
Speaker.
"The
Insulin
Receptor
and
Liver,
Skeletal
Muscle,
and
Adipose
Tissue
from
Humans
with
and
without
Type
II
Diabetes."
Lilly
Diabetes
Care
InternaUonal
Symposium.
Indianapolis,
IN,
1987
Invited
Speaker.
"Mechanisms
of
Insulin
Resistance
in
Type
II
Diabetes."
At
the
"NaUonal
InsUtutes
of
Health
Centennial,
Nurturing
CreaUve
Research
Genius
for
Biomedicine."
Duke
University
School
of
Medicine.
Durham,
NC,
1987
Symposium
Chairman.
"Diabetes
Mellitus:
Management
in
Pregnancy
and
Childhood."
American
Diabetes
AssociaUon
and
East
Carolina
University
School
of
Medicine.
Greenville,
NC,
1987
Invited
Speaker.
"Type
II
Diabetes
Mellitus:
Treatment
and
ComplicaUons."
The
XI
Interamerican
Medical
Congress
of
the
Spanish-­‐American
Medical
Society.
New
York,
NY,
1987
VisiUng
Professor.
"Mechanisms
of
Insulin
Resistance
in
Type
II
Diabetes."
University
of
Virginia
Diabetes
Center,
Charlooesville,
VA,
1987
VisiUng
Professor.
"Role
of
Insulin
Receptor
Tyrosine
Kinase
in
Insulin
Resistance."
Glaxo
Research
Laboratory.
Research
Triangle
Park,
NC,
1987
Invited
Speaker.
"Advances
in
the
Treatment
of
Type
II
Diabetes."
At
the
XII
Annual
Conference
of
the
North
Carolina
Academy
of
Physicians."
Wrightsville,
NC,
1988
Invited
Speaker.
"Carbohydrate
Metabolism
in
Diabetes."
At
the
"IX
Annual
Congress
of
the
Spanish
Society
of
Diabetes."
Barcelona,
Spain,
1988
Invited
Speaker.
"Current
Views
of
EUology
of
Type
II
Diabetes:
Are
We
Gewng
There?"
At
"Diabetes
Update
1988."
American
Diabetes
AssociaUon
and
East
Carolina
University
School
of
Medicine.
Southern
Pines,
NC,
1988
Invited
Speaker.
"The
Insulin
Receptor
in
Obesity
and
NIDDM:
A
New
Target
for
Clinical
and
Basic
Research."
At
a
symposium
on
the
"Mechanism
of
Insulin
Resistance
in
Type
II
Diabetes"
70th
Annual
MeeUng
of
the
Endocrine
Society.
New
Orleans,
LA,
1988
VisiUng
Professor
and
Clinical
Scholar.
Lilly
task
force
on
"Early
RecogniUon
and
PrevenUon
of
Diabetes."
Lilly
Research
Laboratories.
Indianapolis,
IN,
1988
Invited
Speaker.
"DiabeUc
Emergencies."
North
Carolina
Family
Physician's
Annual
MeeUng.
Wrightsville
Beach,
NC,
1988
Invited
Speaker.
"Diabetes."
Geriatric
Medicine
Board
Review.
East
Carolina
University
School
of
Medicine.
Greenville,
NC,
1988
VisiUng
Professor.
"Mechanism
of
Insulin
Resistance
in
Type
II
Diabetes."
Veterans
AdministraUon
Medical
Center
at
Georgetown
University.
Washington,
DC,
1988

18. Invited
Speaker.
"Insulin
Receptor
Kinase
AlteraUons."
At
the
"AcUon
of
Insulin
and
Related
Growth
Factors
in
Diabetes
Mellitus."
CelebraUng
Joslin's
90th
Anniversary.
Joslin
Diabetes
Center
and
Harvard
Medical
School.
Boston,
MA,
1988
VisiUng
Professor.
"Mechanism
of
Insulin
Resistance
in
Type
II
Diabetes."
University
of
Illinois
Chicago,
IL,
1988
VisiUng
Professor.
"Insulin
Resistance."
University
of
California,
San
Diego,
CA,
1988
Invited
Speaker.
"DevastaUon
of
the
Disease:
Type
II
Diabetes."
Third
Hispanic
Medical
Congress.
Washington,
DC,
1988
VisiUng
Professor.
"Mechanism
of
Insulin
Resistance
in
Type
II
Diabetes"
and
"Chronic
ComplicaUons
of
Diabetes."
Diabetes
Branch
of
the
NaUonal
InsUtutes
of
Health.
Bethesda,
MD,
1988
VisiUng
Professor.
"Mechanism
of
Insulin
Resistance
in
Type
II
Diabetes"
and
"Chronic
ComplicaUons
of
Diabetes."
University
of
Colorado
Health
Sciences
Center.
Denver,
Colorado,
1988
VisiUng
Professor.
"Mechanism
of
Insulin
Resistance
in
Type
II
Diabetes."
Diabetes
Clinical
Research
InsUtute,
Charlooesville,
VA,
1989
VisiUng
Professor.
"The
Insulin
Receptor:
A
New
Target
For
Basic
and
Clinical
InvesUgaUons."
Research
Seminar,
Emory
University,
Atlanta,
GA,
1989
VisiUng
Professor.
"Mechanism
of
Insulin
Resistance
in
Type
II
Diabetes."
Diabetes
Center
of
Eastern
Virginia,
Norfolk,
VA,
1989
Invited
Speaker.
"Mechanism
of
Insulin
AcUon."
Inter-­‐University
Post-­‐Graduate
course
on
Molecular
Mechanism
of
the
Endocrine
System,
Fundacion
Ramon
Areces,
Madrid,
Spain,
1989
Keynote
Speaker.
"The
Pathogenesis
of
Obesity"
and
"Meet
the
Professor:
Problem
Case
Discussion."
At
Diabetes
Mellitus
-­‐
Challenges
in
the
1990's."
American
Diabetes
AssociaUon,
Hilton
Head
Island,
SC,
1989
Invited
Speaker.
"Clinical
and
Physiological
Correlates
of
Glucose
Transport
in
Obesity
and
Diabetes"
at
"The
Symposium
in
FronUers
in
the
Molecular
and
Cellular
Biology
and
Glucose
Transport."
49th
Annual
MeeUng
and
ScienUfic
Sessions,
American
Diabetes
AssociaUon,
1989
Invited
Speaker.
"Insulin
Resistance
in
Obesity:
Towards
a
Molecular
Approach."
UCLA
Symposium
on
Molecular
and
Cellular
Biology,
Keystone,
Colorado,
1989
Keynote
Speaker.
"Advances
in
Diabetes
Mellitus"
at
the
Mexican
Society
of
NutriUon
and
Endocrinology,
Monterey,
Mexico,
1989
Keynote
Speaker.
"Obesity
and
Insulin
Resistance"
and
"Meet
the
Professor:
Diabetes
Mellitus
and
Hypertension"
at
the
IV
InternaUonal
Congress
of
Medicine,
Victoria,
Mexico,
1989
Invited
Speaker.
"Studies
on
the
Mechanism
of
Insulin
Resistance
in
Type
II
Diabetes."
Merck,
Sharp,
&
Dohme
Co.
Rahway,
NJ,
1989
Invited
Speaker.
"The
Insulin
Receptor
and
Post
Receptor
in
Liver
in
NIDDM:
Effects
of
Sulfonylureas."
Fourth
InternaUonal
Conference
on
Diabetes.
University
of
Virginia,
Charlooesville,
VA,
1989

19. Keynote
Speaker.
"Cellular
AlteraUons
in
Liver,
Muscle,
and
Adipose
Tissues
Responsible
for
Insulin
Resistance
in
Diabetes."
MeeUng
of
the
Diabetes
Treatment
Centers
of
American
FoundaUon.
1989
Annual
Physicians
Conference.
Palm
Desert,
CA,
1989
Invited
Speaker.
"Diabetes
is
a
Serious
Disease"
42nd
Annual
ScienUfic
Assembly
of
the
North
Carolina
Academy
of
Family
Physicians.
Greensboro,
NC,
1990
Invited
Speaker.
"Cellular
AlteraUons
in
Liver,
Muscle,
and
Adipose
Tissue
Responsible
for
Insulin
Resistance
in
NIDDM."
Hershey
Medical
Center,
Hershey,
PA,
1990
Invited
Speaker.
"AlteraUons
in
Insulin
Receptors
and
Glucose
Transporters
in
Obese
and
DiabeUc
Humans,"
at
the
Satellite
MeeUng
of
the
XI
Amsterdam
InternaUonal
Congress
of
Pharmacology,
"Pathophysiology
and
Treatment
of
Diabetes
Mellitus"
Montpellier,
France,
1990
Invited
Speaker.
"Altered
Coupling
of
the
Insulin
Receptor
with
Gi
Protein
in
the
Liver
from
PaUents
with
NIDDM"
at
the
InternaUonal
Symposium
on
Obesity
and
Diabetes
Mellitus,
Nagoya,
Japan,
1990
Invited
Speaker.
"Insulin
AcUon
in
Adipose
Tissue
and
Muscle
in
Human
Obesity
and
Diabetes"
at
the
6th
InternaUonal
Congress
on
Obesity,
Kobe,
Japan,
1990
Invited
Speaker,
"Diagnosis
and
Treatment
of
Diabetes
Mellitus"
and
"Insulin
Resistance
in
Obesity
and
Diabetes
Mellitus"
at
the
LII
NaUonal
Medical
Congress,
San
Jose,
Costa
Rica,
1990
Invited
Speaker,
"Post-­‐Receptor
Defect
in
Type
II
Diabetes"
American
Diabetes
AssociaUon,
Minneapolis
Affiliate,
Minneapolis,
MN,
1990
Invited
Speaker,
"G-­‐Proteins
in
Diabetes"
at
the
Mayo
Clinic,
Rochester,
NY,
1990
Invited
Speaker,
"Overview
of
AlteraUons
in
Insulin
AcUon
in
Human
Diabetes"
at
the
UCLA
Symposium
on
Molecular
and
Cellular
Biology,
Park
City,
Utah,
1991
Invited
Speaker,
"Mechanism
of
Insulin
Resistance
in
NIDDM."
Miles
Laboratories,
West
Haven,
ConnecUcut,
1991
Invited
Speaker,
"Mechanisms
and
Management
of
Type
II
Diabetes."
New
Mexico
Metabolism
Symposium
1991.
Taos,
New
Mexico,
1991
Invited
Speaker,
"Mechanism
of
Insulin
Resistance
in
Type
II
Diabetes.
"Baylor
College
of
Medicine,
Houston,
Texas,
1991
Invited
Speaker,
"Diabetes
Mellitus
PrevenUon
in
the
High
Risk
PaUent,"
at
the
"Current
Advances
in
NutriUonal
Medicine
and
Disease
PrevenUon."
Harvard
Medical
School,
Boston,
MA,
1991
Invited
Speaker,
"NIDDM:
Insulin
Resistance
vs.
Insulin
SecreUon."
NJ
Affiliate
of
the
ADA,
Jamesburg,
NJ,
1991
Keynote
Speaker,
"Diabetes
in
the
90's."
American
Diabetes
AssociaUon,
NC
Affiliate,
Raleigh,
NC,
1991
Invited
Speaker,
"Insulin
Resistance
in
NIDDM."
University
of
Chicago,
Chicago,
IL,
1991
Invited
Speaker,
"Carbohydrate
Metabolism
in
Obesity
and
Diabetes."
NutriUon
and
Diabetes
Mellitus:
Focus
for
the
1990's.
A
Satellite
Symposium
of
the
14th
IDF
Congress.
BalUmore,
MD,
1991

20. Invited
Speaker,
"Physiology
of
Insulin
AcUon
in
Muscle."
14th
InternaUonal
Diabetes
FederaUon
Congress,
Washington,
DC,
1991
Invited
Speaker,
"Mechanism
of
Insulin
AcUon."
Satellite
Symposium,
14th
IDF
Congress,
Airily,
VA,
1991
VisiUng
Professor,
"Cellular
AlteraUons
in
Liver,
Skeletal
Muscle,
and
Adipose
Tissue
Responsible
for
Insulin
Resistance
in
Obesity
and
Type
II
Diabetes."
Symposium
organized
by
the
USSR
Academy
of
Medical
Sciences
and
the
USSR
Ministry
of
Health,
Moscow,
Russia,
1991
Invited
Speaker,
"The
IGF-­‐1
Receptor
in
NIDDM:
A
Pathway
to
Bypass
Insulin
Resistance?"
39th
Annual
Clinical
Society
ScienUfic
MeeUng
of
the
American
Diabetes
AssociaUon,
New
York
Downstate
Affiliate,
New
York
City,
1991
Invited
Speaker,
"Mechanism
of
Insulin
Resistance
in
Obesity."
Workshop
sponsored
by
the
NaUonal
Diabetes
Advisory
Board,
NaUonal
InsUtutes
of
Health,
Arlington,
VA,
1991
Invited
Speaker,
"Syndrome
X."
11th
Annual
Day
of
Diabetes,
American
Diabetes
AssociaUon,
Columbus,
Georgia,
1992
Invited
Speaker,
"Insulin
Resistance
in
Obesity
and
Non-­‐Insulin
Dependent
Diabetes:
Cause
or
Effect."
Western
Metabolism
Club,
Carmel,
California,
1992
VisiUng
Professor,
"Fat
1992",
Grand
Rounds,
Hospital
of
the
University
of
Pennsylvania,
Philadelphia,
Pennsylvania,
1992
Invited
Speaker,
"Alteraciones
a
nivel
de
receptor
y
post
receptor
en
la
obesidad,"
XXV
Congreso
Nacional
de
la
Sociedad
Española
de
Ciencias
Fisiológicas,
Cordoba,
Spain,
1992
Keynote
Speaker,
"Aspectos
moleculares
de
la
diabetes
mellitus
no
insulinodependiente",
VIII
Congreso
Asociación
LaUnoamericana
de
Diabetes,
Buenos
Aires,
ArgenUna,
1992
Simposium
Speaker,
"Resistencia
insulinica:
su
rol
en
diversos
síndromes,"
VII
Congreso
Asociación
LaUnoamericana
de
Diabetes,
Buenos
Aires,
ArgenUna,
1992
VisiUng
Professor,
"Weight
Loss:
Is
it
a
Miracle?",
Cooper
Hospital/University
of
Medicine
and
DenUstry
of
New
Jersey,
Robert
Wood
Johnson
Medical
School,
Camden,
New
Jersey,
1992
VisiUng
Professor,
"Insulin
Resistance
in
Type
II
Diabetes",
University
of
Piosburgh,
Piosburgh,
Pennsylvania,
1992
VisiUng
Professor,
"Pharmacological
methods
to
bypass
insulin
resistance",
Department
of
Biochemistry,
University
of
Medicine
and
DenUstry
of
New
Jersey/School
of
Osteopathic
Medicine,
Stralord,
New
Jersey,
1992
Invited
Speaker,
"Insulin
Resistance
in
Type
II
Diabetes",
InternaUonal
Diabetes
FederaUon
Congress
and
the
Dominican
Republic
AssociaUon
of
Endocrinology,
Santo
Domingo,
Dominican
Republic,
1993
VisiUng
Professor,
"Insulin
Resistance",
State
University
of
New
York
Health
Science
Center
at
Brooklyn,
Brooklyn,
New
York,
1993
VisiUng
Professor,
"Insulin
Resistance:
A
target
for
the
Clinical
and
Basic
InvesUgator",
The
Milton
S.
Hershey
Medical
Center
of
the
Pennsylvania
State
University,
Hershey,
Pennsylvania,
1993
Invited
Speaker,
"Beyond
the
Basics:
Neuropathy",
the
13th
Annual
Diabetes
Update
'93
-­‐
American
Diabetes
AssociaUon,
Philadelphia,
Pennsylvania,
1993

21. Invited
Speaker,
"Obesity:
A
Disease
of
the
Adipose
Tissue",
NaUonal
InsUtutes
of
Health,
Bethesda,
Maryland,
1993
Invited
Speaker,
"The
ABCs
of
Thyroid
Disease",
Eastern
Shore
Medical
Symposium,
Rehoboth
Beach,
Delaware,
1993
VisiUng
Professor,
"Gene
Therapy
for
Insulin
Resistance",
Department
of
Biochemistry,
School
of
Medicine,
Universidad
Complutense,
Madrid,
Spain,
1993
Keynote
Speaker,
"Diabetes
in
LaUnos"
8th
Hispanic
Medical
Congress.
The
Interamerican
College
of
Physicians
and
Surgeons,
San
Juan,
Puerto
Rico,
1993
Invited
Speaker,
"The
TranslaUon
of
the
DCCT
to
the
Care
of
PaUents
with
Type
II
Diabetes
Mellitus"
The
Opening
Symposium
of
the
Joslin
Center
for
Diabetes
at
Jefferson
Medical
College
and
Wills
Eye
Hospital,
Philadelphia,
1994
Invited
Speaker,
"Weight
Loss
in
Severely
Obese
Subjects
Prevents
Type
II
Diabetes"
InternaUonal
Symposium
sponsored
by
the
Chinese
NutriUon
Society
and
Shanghai
NutriUon
Society.
Beijing,
China,
1994
Invited
Speaker,
"Thyroid
Nodules"
Diabetes-­‐Endocrine
Symposium,
Medical
College
of
Pennsylvania,
Philadelphia,
Pennsylvania,
1994
Leadership
Workshop:
"TherapeuUc
Choices
in
NIDDM”
54th
Annual
MeeUng,
American
Diabetes
AssociaUon,
New
Orleans,
1994
Invited
Speaker,
"Morbid
Obesity
and
Diabetes"
7th
InternaUonal
Congress
of
Obesity
Satellite
Symposium
on
Surgical
Treatment
of
Obesity,
Montreal,
Quebec,
Canada,
1994
Keynote
Speaker,
"Insulin
Resistance
from
the
laboratory
to
the
bedside",
XVI
Internal
Medicine
Chilean
Congress,
SanUago,
Chile,
1994
Symposium
Speaker,
"Current
and
future
treatment
of
Diabetes
Mellitus",
XVI
Internal
Medicine
Chilean
Congress,
SanUago,
Chile,
1994
Invited
Speaker,
"PrevenUon
of
diabetes:
Is
it
possible?
",
XVI
Internal
Medicine
Chilean
Congress,
SanUago,
Chile,
1994
Invited
Speaker,
"Insulin
Analogs"
American
Diabetes
AssociaUon,
Northern
Illinois
Affiliate’s
Thirty-­‐Seventh
Annual
Professional
Symposium,
Chicago,
1994
Invited
Speaker,
"The
TranslaUon
of
the
DCCT
to
the
Care
of
the
PaUent
with
Type
II
Diabetes
Mellitus",
The
Third
Annual
Controversies
in
Ambulatory
Care
Medicine,
Philadelphia,
1994
VisiUng
Professor,
"PrevenUon
of
Type
II
Diabetes:
The
Challenge
of
the
Next
Decade",
Medical
Grand
Rounds,
UMDNJ-­‐Robert
Wood
Johnson
Medical
School,
New
Brunswick,
NJ,
1995
VisiUng
Professor,
“The
PromoUon
of
the
Adipocyte:
from
storage
to
an
endocrine
cell”,
Grand
Rounds,
University
of
Southern
California
School
of
Medicine,
Los
Angeles,
CA,
1995
VisiUng
Professor,
“¿Es
el
adiosito
inteligente?”,
Consejo
Superior
de
InvesUgaciones
Cien~ficas,
Madrid,
Spain,
1995

22. Leadership
Workshop:
"Insulin
AcUon
Enhancers”,
55th
Annual
MeeUng,
American
Diabetes
AssociaUon,
Atlanta,
Georgia,
1995
Invited
Speaker,
“Impact
of
weight
loss
by
surgery
on
metabolic
fitness”,
FASEB
Summer
Conference
on
GeneUc
and
Behavioral
Influences
on
Nutrient
Metabolism
and
Obesity,
Copper
Mountain,
Colorado,
1995
VisiUng
Professor,
“Ob
protein
resistance
in
human
obesity”,
University
of
Chicago,
Chicago,
Illinois,
1995
Plenary
Speaker,
“Studies
of
LepUn
in
Human
Subjects”,
NAASO
MeeUng,
Baton
Rouge,
Louisiana,
1995
Symposium
Speaker,
“The
Gut
and
NIDDM”,
Precose
Specialist
InvesUgator
MeeUng,
Lincolnshire,
IL,
1995
VisiUng
Professor,
“¿Terapia
molecular
de
la
diabetes
o
de
la
obesidad?”,
V
Congreso
de
Ciencias
FarmacéuUcas,
Madrid,
Spain,
1995
Symposium
Speaker,
“Obesidad
e
insulino
resistencia”,
Sociedad
Mexicana
de
Nutrición
y
Endocrinologia,
Guanajuato,
Mexico,
1995
Symposium
Speaker,
“LepUn:
The
sensor
of
either
fact
mass
or
energy
balance?”,
American
Society
for
Parenteral
and
Enteral
NutriUon,
Washington,
DC,
1996
Symposium
Speaker,
“Advances
en
Fisiopatologia
de
la
Obesidad”,
Canary
Islands,
Spain,1996
Invited
Speaker,
“The
Ob
Gene
in
Human
Obesity”,
Western
Metabolism
Club,
Carmel,
CA,
1996
Invited
Speaker,
“Ob
Protein
in
Human
Obesity”,
IBC’s
Second
Annual
InternaUonal
Symposium,
Washington,
DC,
1996
Invited
Speaker,
“New
Insights
into
the
Pathophysiology
and
Therapy
of
Obesity:
The
LepUn
Story”,
Sixteenth
MeeUng
of
the
InternaUonal
ScienUfic
Commioee
on
Diabetes,
Cologne,
Germany,
1996
Invited
Speaker,
“Obesity:
A
GeneUc
Disease?”,
Fourth
ScienUfic
Course
in
PancreaUc
Islet
Physiology
and
Pathology,
Barcelona,
Spain,
1996
Invited
Speaker,
“Obesity:
What
Can
be
Done?”,
Clinical
Endocrinology,
Harvard
Medical
School,
Boston,
MA,
1996
Invited
Speaker,
"Human
Obesity:
What
Have
We
Learned
from
Recent
GeneUc
Insights?",
Biomedicine
'96,
Washington,
D.C.,
1996
VisiUng
Professor,
"LepUn:
The
Tale
of
an
Obesity
Gene,
Part
II:
Rx:
LepUn
Sc,
qday
and
eat
anything
you
want
,
East
Carolina
University,
Greenville,
NC,
1996
Invited
speaker,
"LepUn
Physiology
and
Pathophysiology
in
Man",
American
Society
for
Clinical
InvesUgaUon,
Washington,
D.C.,
1996
Symposium
Speaker,
"Molecular
therapy
of
obesity
or
diabetes?
That
is
the
quesUon",
XIII
MeeUng
of
the
Spanish
Diabetes
Society,
Oviedo,
Spain,
1996
Keynote
speaker,
"LepUn:
The
tale
of
an
obesity
gene:
American
Diabetes
AssociaUon,
Amelia
Island,
Florida,
1996
Symposium
Speaker:
“Obesity
and
Diabetes”
4th
Annual
Congress
on
Women’s
Health,
Washington,
D.C.,
1996
Invited
Speaker,
“LepUn:
The
Tale
of
an
Obesity
Gene”
Annual
Research
Symposium,
The
InsUtute
of
NutriUon,
University
of
North
Carolina,
Chapel
Hill,
NC,
1996

23. Invited
Speaker,
“Ob
Protein
in
Human
Obesity”
IBC’s
Third
InternaUonal
Symposium
-­‐
Obesity
-­‐
Advances
in
Understanding
and
Treatment.
San
Diego,
CA,
1996
Invited
Speaker,
“MeeUng
the
Needs
of
paUents:
Emerging
OpUons
in
Diabetes
Care”.
34th
Annual
MeeUng
of
the
European
AssociaUon
for
the
Study
of
Diabetes.
Vienna,
Austria,
1996
Invited
Speaker.
“Obesity
as
a
Metabolic
Disease”.
6th
Annual
Turamberry
Conference.
Aventura,
Florida,
1996
Invited
Speaker.
“The
ob
Gene
Product
and
Nutrient
Balance”.
North
American
AssociaUon
for
the
Study
of
Obesity.
Breckenridge,
Colorado,
1996
Invited
Speaker.
XXVI
Congreso
de
la
Asociación
Española
de
Pediatria.
Valencia,
Spain,
1996
Invited
Speaker.
Human
Obesity:
Beyond
LepUn
ProducUon.
InternaUonal
Congress
on
AnU-­‐Obesity
Drug
Targets.
Cambridge,
MA.,
1996
Invited
Speaker.
Insulina
y
lepUna:
La
Extraña
Pareja.
VIII
Congreso
Sociedad
Valenciana
de
Endocrinologia,
Diabetes
y
nutrición.
Valencia,
Spain,
1996
Invited
Speaker.
Chapter
One
in
the
Story
of
LepUn
in
Humans.
American
Society
for
Clinical
Pharmacology
and
TherapeuUcs.
San
Diego,
CA,
1997
Invited
Speaker.
“Pathophysiology
of
Obesity”.
Symposium
of
the
German
Endocrine
Society.
Lübeck,
Germany,
1997.
Invited
Speaker.
“LepUn:
The
Second
Year”.
2nd
World
Conference
of
the
InternaUonal
Society
for
Molecular
NutriUon
and
Therapy.
Winnipeg,
Canada,
1997.
Invited
Speaker.
"LepUn:
From
Rodents
to
Humans".
InternaUonal
Diabetes
FederaUon
Congress,
Helsinki,
Finland,
1997
Invited
Speaker.
“LepUn:
The
New
Lean
Gene”.
European
Congress
of
Clinical
Chemistry
“Medlab97”,
Basel,
Switzerland,
1997
Invited
Speaker.
Grand
Rounds.
"LepUn:
From
Rodents
to
Humans".
Tulane
University,
New
Orleans,
Louisiana,
1997
Invited
Speaker,
Plenary
Session.
"Current
and
Future
ImplicaUons
For
the
Use
of
LepUn
in
the
Treatment
of
Obesity".
NAASO
Annual
MeeUng,
Cancun,
Mexico,
1997
Invited
Speaker,
Conferencia
“Diabetes,
obesity
y
lepUn”.
Simposia
Harvard
-­‐
Joslin
-­‐
SBD,
XI
Congreso
Brasileño
de
Diabetes,
Porto
Alegre,
Brazil
1997
Medical
Grand
Rounds
-­‐
“The
Role
of
LepUn
in
Body
Weight
RegulaUon”.
The
University
of
Texas.
San
Antonio,
TX,
1997
Research
Seminar:
“Strategies
for
the
treatment
of
type
II
diabetes”.
Garvan
InsUtute.
Sydney,
Australia,
1997
Research
Seminar:
“Recent
Advances
on
LepUn”.
The
Walter
and
Eliza
Hall
InsUtute
for
Medical
Research.
Melbourne,
Australia,
1997
Plenary
Lecturer:
“Strategies
for
the
treatment
of
Obesity”.
NAASO
and
American
Society
of
Clinical
NutriUon.
Merida,
Mexico,
1997

24. Congreso
Nacional
de
la
Sociedad
Española
de
Diabetes
y
Obesidad:
“LepUna
y
obesidad".
Caceres,
Spain,
1997
Invited
Speaker
-­‐
Bio-­‐chemistry
Seminar:
“Strategy
of
drug
discovery
for
the
treatment
of
obesity”.
Indiana
University
Medical
Center.
Indianapolis,
IN,
1998
Invited
Speaker:
American
Diabetes
AssociaUon
“LepUn
Pathway
as
a
Target
for
Treatment”.
San
Francisco,
California,
1998
Invited
Speaker:
“Addressing
the
AcceleraUng
Cost
of
Chronic
Diseases:
A
Case
Study”.
MeeUng
the
21st
century
healthcare
challenge:
A
New
Vision
for
PharmaceuUcal
InnovaUon.
PHRMA,
U.S.
Embassy.
Tokyo,
Japan,
1998
Opening
Lecture
of
the
XIV
Sociedad
Española
de
Diabetes:
“En
el
camino
a
la
cura
de
la
Diabetes”
Murcia,
Spain,
1998
Keynote
lecture:
“A
new
endocrine
cell:
Biology
and
FuncUon
of
Adipocytes”
71st
Annual
MeeUng
of
the
Japan
Endocrine
Society.
Fukuoka,
Japan,
1998
Plenary
lecture:
“LepUn:
the
Past,
Present
and
Future”.
71st
Annual
MeeUng
of
the
Japan
Endocrine
Society.
Fukuoka,
Japan,
1998
Plenary
lecture:
“From
New
Genes
to
New
Treatments”.
Satellite
Symposium
of
the
8th
InternaUonal
Congress
on
Obesity.
Paris,
France,
1998
Plenary
lecture:
“Emerging
Therapies
for
Type
II
Diabetes”.
34th
Annual
MeeUng
of
the
European
AssociaUon
for
the
Study
of
Diabetes.
Barcelona,
Spain,
1998
Conferencia
Magistral
-­‐
Hospital
Maciel:
“
LepUna
la
Voz
Del
Adiosito”.
Simposio
Obesidad
y
Diabetes
Mellitus
-­‐
Cuando
Y
Como
Intervenir.
Montevideo,
Uruguay,
1998
Conferencia
Magistral
-­‐
Hospital
Maciel:
“Intervenciones
Futuras
en
el
Manejo
de
la
Obesidad.
Montevideo,
Uruguay,
1998
Lilly
Symposium
-­‐
Temas
actuales
en
Diabetes.
“LepUna
y
Obesidad”.
Montevideo,
Uruguay,
1998
Invited
Speaker:
“Opciones
terapéuUcas
en
el
síndrome
de
insulinorresistencia”.
XI
Congreso
ArgenUno
de
Diabetes.
Cordoba,
ArgenUna,
1998
Invited
Speaker:
“LepUna
y
Obesidad”.
XI
Congreso
ArgenUno
de
Diabetes.
Cordoba,
ArgenUna,
1998
Opening
Lecture:
“LepUna:
La
voz
del
Adiosito”.
III
Curso
Sobre
InvesUgaciones
Biomedicas,
Universidad
de
Granada
y
Consejo
Superior
de
InvesUgaciones
Cien~ficas.
Granada,
Spain,
1998
Symposium
Speaker:
“New
Molecular
Target
for
the
treatment
of
Obesity”.
“VI
MeeUng
on
Lipid
Metabolism
and
Related
Pathology”
InsUtuto
Superior
de
Ciencias
da
Sande-­‐Sul.
Costa
da
Caprica,
Portugal,
1998
Symposium
Chairman
and
Speaker:
“Neuroendocrine
integraUon
of
appeUte".
Experimental
Biology
‘99
MeeUng.
Washington,
D.C.
1999
Invited
Speaker:
"LepUn:
The
tale
of
an
obesity
gene
and
it's
applicaUon
to
children".
Building
Bright
Futures:
Neonatal,
Pediatric
and
Adolescent
NutriUon
in
the
21st
Century.
Indiana
University
School
of
Medicine,
Indianapolis,
IN.
1999

25. Symposium
Co-­‐Chairman
and
Speaker.
"On
the
trail
to
cure
obesity".
GeneUcs,
Pathophysiology
and
TherapeuUcs
on
the
Eve
of
a
Major
Conceptual
RevoluUon.
Euro-­‐Conference
InsUtute
Pasteur.
Paris,
France,
1999
Invited
Speaker:
"Insulin
Resistance:
A
target
for
drug
therapy
at
the
CMES
Ancillary
Symposium,
The
Endocrine
Society.
Toronto,
Canada,
2000
VisiUng
Professor:
“New
targets
for
the
treatment
of
obesity”.
Medical
Grand
Rounds,
University
of
Piosburgh
School
of
Medicine.
Piosburgh,
PA.
2001
Invited
Speaker:
“The
treatment
of
diabetes
in
the
new
Millennium.
Italian
Society
of
Diabetes.
Florence,
Italy,
2002
Symposium
Speaker:
“New
Drug
Therapies
for
Obesity”
at
Obesity:
Molecular
Causes
and
New
Pathways
for
Treatment
and
PrevenUon.
American
AssociaUon
for
the
Advancement
of
Science
(AAAS)
Annual
MeeUng.
Denver,
Colorado.
2003
Keynote
Speaker:
“The
Do’s
and
Do
Not’s
in
Science:
From
Fuller
Albright
to
the
Present”.
Graduate
Student
Research
Day.
East
Carolina
University.
Greenville,
NC.
2003
Symposium
Speaker:
“Obesity
and
the
Metabolic
Syndrome:
IdenUfying
Underlying
Mechanisms
and
Emerging
Therapies
for
Pharmacological
Treatment”.
PharmaceuUcal
EducaUon
Associates.
Washington,
DC.
2003.
Roundtable
ParUcipant:
“Obesity
and
Cancer”
NaUonal
Dialogue
on
Cancer.
Sponsored
by
President
George
W.
and
Barbara
Bush.
Kennebunkport,
Maine.
2003
Keynote
Speaker
and
Chairperson:
“OpportuniUes
and
Challenges
of
TherapeuUc
Development
for
Obesity”.
World
Obesity
Congress
&
Expo.
Washington,
DC.
2004
Symposium
Speaker:
“Addressing
the
Obesity
Epidemic:
From
Bench
to
Bedside
to
Market”.
The
Endocrine
Society’s
86th
Annual
MeeUng.
New
Orleans,
LA.
2004
Invited
Speaker:
“Overcoming
Diabetes:
A
Long
March
from
Discovery
to
CommercializaUon”.
The
Opening
Ceremony
of
the
Peking
University
Diabetes
Center.
Beijing,
China.
2004
Invited
Speaker:
“AnU-­‐Obesity
Drug
Development:
From
Target
IdenUficaUon
to
Launch”.
NAASO
2004
ScienUfic
MeeUng.
Las
Vegas,
NV.
2004
Invited
Speaker:
“New
Therapies
for
Diabetes”.
Leerink
Swann/MEDACorp.
Inaugural
Health
Care
Conference.
New
York,
NY.
2005
Invited
Speaker:
“Insulin
SensiUvity
Enhancers
for
the
Treatment
and
PrevenUon
of
Diabetes“
Diabetes
and
Obesity
Research
Day.
East
Carolina
University,
Brody
School
of
Medicine.
Greenville,
NC.
2005
Keynote
Speaker
and
Chairperson:
“New
OpportuniUes
and
Challenges
of
TherapeuUc
Developments
with
Obesity
and
Weight
Loss”.
World
Obesity
Congress
&
Expo.
Washington,
DC.
2005
Keynote
Speaker:
“On
the
Trail
to
ARREST
the
Progression
of
Type
2
Diabetes”
College
of
Agriculture
and
Life
Sciences,
University
of
Arizona.
Phoenix,
AZ.
2005
Keynote
Speaker:
“On
the
Trail
to
ARREST
the
Progression
of
the
Metabolic
Syndrome”
8th
Symposium
Fundacion
Lilly
“New
Approaches
to
the
Metabolic
Syndrome”
San
Lorenzo
de
El
Escorial,
Madrid.
2005
Invited
Speaker:
“May
be
difficult
at
Umes…?”
At
The
5th
NaUonal
Metabolic
Day.
Utrecht
University,
Amsterdam,
The
Nederland
2006

26. Keynote
Speaker:
“Diabesity”
13th
Annual
Kaiser
Permanente
Diabetes
Symposium.
Woodland
Hills,
CA
2007
Invited
Speaker
and
panel
member:
“Clinical
Trials,
Sewng
the
stage
for
the
future”.
At
the
inaugural
Clinical
Trial
Regional
Exchange
Group,
The
North
Carolina
Biotechnology
Center.
Greenville
NC,
2007
Post
Graduate
Course
in
Endocrinology:
“Obesity”.
At
the
Universidad
Catolica,
Montevideo,
Uruguay,
2008
Invited
Speaker:
“Peers
for
Progress”.
At
the
School
of
Medicine,
Maciel
Hospital.
Montevideo,
Uruguay,
2008
PUBLICATIONS
1. Caro,
J.F.,
A.
Besarab,
J.R.
Burke,
and
J.A.
Glennon.
Propranolol:
A
possible
role
in
the
treatment
of
renal
osteodystrophy.
Lancet
II:451,1978.
2. Caro,
J.F.,
and
A.
Besarab.
Propranolol
therapy
for
hyperparathyroidism.
Lancet
II:827,1978.
3. Caro,
J.F.,
A.W.
Meikle,
J.H.
Check,
and
S.N.
Cohen.
"Normal
suppression"
to
dexamethasone
in
Cushing's
disease:
An
expression
of
decreased
metabolic
clearance
for
dexamethasone.
J.
Clin.
Endocrinol.
Metab.
47:667,1978.
4. Ballas,
S.K.,
J.F.
Caro,
and
O.
Miguel.
Quinidine-­‐induced
hemolyUc
anemia:
Immunohematologic
characterizaUon.
Transfusion
18:215,1978.
5. Besarab,
A.,
and
J.F.
Caro.
Mechanism
of
hypercalcemia
in
malignancy.
Cancer
6:2276,1978.
6. Caro,
J.F.,
A.
Besarab,
and
J.A.
Glennon.
SymptomaUc
hypocalcemia
following
combined
calcitonin
and
mithramycin
therapy
for
hypercalcemia
in
malignancy.
Cancer
Treat
Reports
62:1561,1978.
7. Check,
J.H.,
J.F.
Caro,
L.
Jackson,
K.
Nowroozn
and
A.F.
Rakoff.
Clinical
mixed
gonadal
dysgenesis
without
Y
chromosome.
Am.
J.
Obstet.
Gynecol.
131:346,1978.
8. Check,
J.H.,
J.F.
Caro,
and
J.T.
Flynn.
CysUc
gynecomasUa
in
a
male
treated
with
clomiphene
citrate.
Infert.
Sterility
30:713,1978.
9. Caro,
J.F.,
A.
Besarab,
and
J.T.
Flynn.
Prostaglandin
E
and
hypercalcemia
in
breast
carcinoma:
Only
a
tumor
marker?
A
need
for
prospecUve.
Am.
J.
Med.
66:337,1979.
10. Caro,
J.F.,
H.L.
Israel,
and
J.A.
Glennon.
Galactorrhea
in
sarcoidosis:
Dynamic
studies
of
prolacUn,
growth
and
gonadotropic
hormone
levels.
Am.
J.
Med.
Sci.
277:1,1979.
11. Check,
J.H.,
J.F.
Caro,
B.
Kendall,
L.A.
Peris,
and
B.L.
Wellenback.
Cushing's
syndrome
in
pregnancy:
Effect
of
associated
diabetes
on
fetal
and
neonatal
complicaUons.
Am.
J.
Obstet.
Gynecol.
44:846,1979.
12. Check,
J.H.,
J.F.
Caro,
L.
Criden,
R.
Meltz,
and
K.
Brownstein.
Leyding
cell
responsiveness
with
gonadal
cell
resistance
to
gonadotropin
therapy
in
Kallman's
syndrome.
Am.
J.
Med.
67:495,1979.

27. 13. Caro,
J.F.,
J.H.
Castro,
and
J.A.
Glennon.
Effect
of
long-­‐term
propranolol
administraUon
on
parathyroid
hormone
and
calcium
concentraUon
in
primary
hyperparathyroidism.
Ann.
Int.
Med.
91:740,1979.
14. Caro,
J.F.,
N.G.
Sloane,
and
J.A.
Glennon.
Hyperthyroidism
with
normal
serum
T4,
T3
and
TBG
immunoreacUvity.
J.
Clin.
Pat.
33:868,1980.
15. Caro,
J.F.,
and
P.D.
Woolf.
Pituitary-­‐ovarian
axis
responsiUvity
to
prolonged
GnRH
infusion
in
normal
and
hyperprolacUnemic
women.
J.
Clin.
Endo.
Metab.
50:999,1980.
16. Insogna,
K.L.,
D.R.
Bordley,
J.F.
Caro,
and
D.H.
Lockwood.
Osteomalacia
and
weakness
due
to
excessive
antacid
ingesUon.
J.A.M.A.
244:2544,1980.
17. Castro,
J.H.,
J.F.
Caro,
Kim,
and
J.A.
Glennon.
Effects
of
PTH
infusion
in
primary
hyperparathyroidism
on
plasma
prolacUn
in
man.
J.
Clin.
Endo.
Metab.
51:397,1980.
18. Caro,
J.F.,
and
J.M.
Amatruda.
FuncUonal
relaUonship
between
insulin
binding,
acUon
and
degradaUon.
J.
Biol.
Chem.
255:10052,1980.
19. Caro,
J.F.,
and
J.M.
Amatruda.
Insulin
receptors
in
hepatocytes:
Post
receptor
events
mediate
down
regulaUon.
Science
210:1029,1980.
20. Caro,
J.F.,
and
J.M.
Amatruda.
The
effects
of
fasUng
on
glucagon
binding
and
acUon
in
isolated
hepatocytes.
Metabolism
29:732,1980.
21. Caro,
J.F.
and
J.A.
Glennon,
and
H.L.
Israel.
Neuroendocrine
studies
in
sarcoidosis.
William,
J.W.
and
Davis,
B.
H.
(Eds.),
Alpha
Omega
Publ.
pp.587,1980.
22. Cech,
J.N.,
R.B.
Freeman,
J.F.
Caro,
and
J.M.
Amatruda.
Insulin
acUon
and
binding
in
isolated
hepatocytes
from
fasted,
streptozotocin
diabeUc
and
older,
spontaneously
obese
rats.
Biochem.
J.
188:839,1980.
23. Caro,
J.F.,
and
J.M.
Amatruda.
Evidence
for
the
modulaUon
of
insulin
acUon
and
degradaUon
independently
of
insulin
binding.
Am.
J.
Physiol.
240:E325,1981.
24. Besarab,
A.,
J.F.
Caro,
B.U.
Ihle,
J.F.
Burke,
and
J.A.
Glennon.
Suppression
of
secondary
hyperparathyroidism
by
propranolol
in
renal
failure
paUent.
Nephron
27:127,1981.
25. Besarab,
A.
and
J.F.
Caro.
Increased
absolute
calcium
binding
to
albumin
in
hypoalbuminaemia.
J.
Clin.
Path.
34:1368,1981.
26. Basal,
S.,
P.D.
Woolf,
J.A.
Fischer,
and
J.F.
Caro.
Dopamine
does
not
affect
parathyroid
funcUon
in
man.
J.
Clin.
Endo
Metab.
54:651,1982.
27. Caro,
J.F.,
and
J.M.
Amatruda.
The
regulaUon
of
lipid
synthesis
in
freshly
isolated
hepatocytes
and
primary
cultures
of
hepatocytes
from
fasted
rats:
The
primary
role
of
insulin.
Metabolism
31:14,1982.
28. Caro,
J.F.,
and
J.M.
Amatruda.
GlucocorUcoid-­‐induced
insulin
resistance:
The
importance
of
post
receptor
events
in
the
regulaUon
of
insulin
binding
and
degradaUon.
J.
Clin.
Invest.
69:866,1982.
29. Caro,
J.F.,
G.
Muller
and
J.A.
Glennon.
Insulin
processing
by
the
liver.
J.
Biol.
Chem.
257:8459,1982.
30. Kauffman,
J.M.,
and
J.F.
Caro.
Insulin
resistance
in
uremia:
CharacterizaUon
of
insulin
acUon
binding
and
processing
in
isolated
hepatocytes
from
chronic
uremic
rat.
J.
Clin.
Invest.
71:698,1983.